HOTTA MASATOSHI 堀田昌利

Researcher Number	30782932
Other IDs	https://orcid.org/0000-0001-6790-8804
Affiliation (Current)	2024: 国立研究開発法人国立国際医療研究センター, その他部局等, 放射線核医学科診療科長
Affiliation (based on the past Project Information) *help	2022 – 2023: 国立研究開発法人国立国際医療研究センター, その他部局等, 放射線核医学科医師 2017 – 2020: 国立研究開発法人国立国際医療研究センター, その他部局等, 放射線核医学科医師
Review Section/Research Field	Principal Investigator Basic Section 52040:Radiological sciences-related / Digestive surgery
Keywords	Principal Investigator PET / 食道癌 / FDG / 4DST / 予後予測 / DNA合成 / 分子イメージング / 放射線医学 / PET/CT

Predicting prognosis in patients with esophageal cancer: Radiomics analysis with DNA synthesis PET imagingPrincipal Investigator
- Principal Investigator
  
  堀田昌利
- Project Period (FY)
  2021 – 2024
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 52040:Radiological sciences-related
- Research Institution
  National Center for Global Health and Medicine
Efficacy of novel DNA synthesis imaging (4DST-PET) as a biomarker of esophageal cancerPrincipal Investigator
- Principal Investigator
  
  HOTTA MASATOSHI
- Project Period (FY)
  2017 – 2019
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Digestive surgery
- Research Institution
  National Center for Global Health and Medicine

All 2019 2018

All Journal Article Presentation

[Journal Article] Efficacy of 4′-[methyl-11C] thiothymidine PET/CT before and after neoadjuvant therapy for predicting therapeutic responses in patients with esophageal cancer: a pilot study2019
- Author(s)
  Hotta Masatoshi、Minamimoto Ryogo、Yamada Kazuhiko、Nohara Kyoko、Soma Daisuke、Nakajima Kazuhiko、Toyohara Jun、Takase Kei
- Journal Title
  
  EJNMMI Research
  
  Volume: 9 Issue: 1 Pages: 10-10
- DOI
  10.1186/s13550-019-0478-9
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18K07658, KAKENHI-PROJECT-17K18396, KAKENHI-PROJECT-17K10618
[Presentation] Efficacy of 4’-[methyl-11C] thiothymidine PET/CT before and after neoadjuvant therapy for predicting therapeutic responses in patients with esophageal cancer.2018
- Author(s)
  Masatoshi Hotta
- Organizer
  SNMMI 2018 The Society of Nuclear Medicine and Molecular Imaging, Philadelphia, PA, USA, June 23-26, 2018.
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K18396
[Presentation] Comparison of 4DST and FDG PET/CT for predicting response to neoadjuvant therapy in patients with esophageal cancer2018
- Author(s)
  堀田昌利
- Organizer
  ECR (European Congress of Radiology) 2018
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K18396
[Presentation] Efficacy of combining FDG PET/CT and 4’-[methyl-11C] thiothymidine (4DST) PET/CT for predicting response to neoadjuvant therapy in patients with esophageal cancer.2018
- Author(s)
  堀田昌利
- Organizer
  ECR (European Congress of Radiology) 2018
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K18396

1. TOYOHARA Jun

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

HOTTA MASATOSHI 堀田昌利

Research Projects

Research Products

Co-Researchers

Predicting prognosis in patients with esophageal cancer: Radiomics analysis with DNA synthesis PET imagingPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Efficacy of novel DNA synthesis imaging (4DST-PET) as a biomarker of esophageal cancerPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Efficacy of 4′-[methyl-11C] thiothymidine PET/CT before and after neoadjuvant therapy for predicting therapeutic responses in patients with esophageal cancer: a pilot study2019

Author(s)

Journal Title

DOI

Data Source

[Presentation] Efficacy of 4’-[methyl-11C] thiothymidine PET/CT before and after neoadjuvant therapy for predicting therapeutic responses in patients with esophageal cancer.2018

Author(s)

Organizer

Data Source

[Presentation] Comparison of 4DST and FDG PET/CT for predicting response to neoadjuvant therapy in patients with esophageal cancer2018

Author(s)

Organizer

Data Source

[Presentation] Efficacy of combining FDG PET/CT and 4’-[methyl-11C] thiothymidine (4DST) PET/CT for predicting response to neoadjuvant therapy in patients with esophageal cancer.2018

Author(s)

Organizer

Data Source

HOTTA MASATOSHI 堀田 昌利

Research Projects

Research Products

Co-Researchers

Predicting prognosis in patients with esophageal cancer: Radiomics analysis with DNA synthesis PET imagingPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Efficacy of novel DNA synthesis imaging (4DST-PET) as a biomarker of esophageal cancerPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Efficacy of 4′-[methyl-11C] thiothymidine PET/CT before and after neoadjuvant therapy for predicting therapeutic responses in patients with esophageal cancer: a pilot study2019

Author(s)

Journal Title

DOI

Data Source

[Presentation] Efficacy of 4’-[methyl-11C] thiothymidine PET/CT before and after neoadjuvant therapy for predicting therapeutic responses in patients with esophageal cancer.2018

Author(s)

Organizer

Data Source

[Presentation] Comparison of 4DST and FDG PET/CT for predicting response to neoadjuvant therapy in patients with esophageal cancer2018

Author(s)

Organizer

Data Source

[Presentation] Efficacy of combining FDG PET/CT and 4’-[methyl-11C] thiothymidine (4DST) PET/CT for predicting response to neoadjuvant therapy in patients with esophageal cancer.2018

Author(s)

Organizer

Data Source

HOTTA MASATOSHI 堀田昌利